Antiprion prophylaxis by gene transfer of a soluble prion antagonist

American Journal of Pathology

Volumn 172, Issue 5, 2008, Pages 1287-1296

  Genoud, Nicolas ^a,d   Ott, David ^a,f   Braun, Nathalie ^a   Prinz, Marco ^a,e   Schwarz, Petra ^a   Suter, Ueli ^b   Trono, Didier ^c   Aguzzi, Adriano ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c EPFL   (Switzerland)

^d SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^e UNIVERSITY OF FREIBURG   (Germany)

^f Institute of Chemical Sciences and Engineering   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PRION PROTEIN; PROTEIN PRP FC2;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; GENE TRANSFER; LENTIVIRINAE; MOUSE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; SINGLE DRUG DOSE; VIRUS GENE;

EID: 43449112676     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.070836     Document Type: Article

References (40)

1. A Aguzzi CJ Sigurdson Antiprion immunotherapy: to suppress or to stimulate? Nat Rev Immunol 4 2004 725 736
2. A Aguzzi M Glatzel F Montrasio M Prinz FL Heppner Interventional strategies against prion diseases Nat Rev Neurosci 2 2001 745 749
3. AR White P Enever M Tayebi R Mushens J Linehan S Brandner D Anstee J Collinge S Hawke Monoclonal antibodies inhibit prion replication and delay the development of prion disease Nature 422 2003 80 83
4. FL Heppner C Musahl I Arrighi MA Klein T Rulicke B Oesch RM Zinkernagel U Kalinke A Aguzzi Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies Science 294 2001 178 182
5. L Solforosi JR Criado DB McGavern S Wirz M Sanchez-Alavez S Sugama LA DeGiorgio BT Volpe E Wiseman G Abalos E Masliah D Gilden MB Oldstone B Conti RA Williamson Cross-linking cellular prion protein triggers neuronal apoptosis in vivo Science 303 2004 1514 1516
6. A Schwarz O Kratke M Burwinkel C Riemer J Schultz P Henklein T Bamme M Baier Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent Neurosci Lett 350 2003 187 189
7. M Polymenidou FL Heppner EC Pellicioli E Urich G Miele N Braun F Wopfner H Schaetzl B Becher A Aguzzi Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection Proc Natl Acad Sci USA 101 2004 14670 14676
8. P Meier N Genoud M Prinz M Maissen T Rulicke A Zurbriggen AJ Raeber A Aguzzi Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease Cell 113 2003 49 60
9. A Follenzi L Naldini Generation of HIV-1 derived lentiviral vector Methods Enzymol 346 2002 454 465
10. F Tronche C Kellendonk O Kretz P Gass K Anlag PC Orban R Bock R Klein G Schutz Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety Nat Genet 23 1999 99 103
11. S Marino M Vooijs H van Der Gulden J Jonkers A Berns Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum Genes Dev 14 2000 994 1004
12. DP Leone S Genoud S Atanasoski R Grausenburger P Berger D Metzger WB Macklin P Chambon U Suter Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells Mol Cell Neurosci 22 2003 430 440
13. R Zufferey D Nagy RJ Mandel L Naldini D Trono Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo Nat Biotechnol 15 1997 871 875
14. M Polymenidou K Stoeck M Glatzel M Vey A Bellon A Aguzzi Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease Lancet Neurol 4 2005 805 814
15. M Kawe A Plückthun GroEL walks the fine line: the subtle balance of substrate and co-chaperonin binding by GroEL. A combinatorial investigation by design, selection and screening J Mol Biol 357 2006 411 426
16. N Genoud A Behrens G Miele D Robay FL Heppner S Freigang A Aguzzi Disruption of Doppel prevents neurodegeneration in mice with extensive Prnp deletions Proc Natl Acad Sci USA 101 2004 4198 4203
17. S Brandner A Raeber A Sailer T Blattler M Fischer C Weissmann A Aguzzi Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system Proc Natl Acad Sci USA 93 1996 13148 13151
18. H Büeler A Raeber A Sailer M Fischer A Aguzzi C Weissmann High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene Mol Med 1 1994 19 30
19. M Fischer T Rülicke A Raeber A Sailer M Moser B Oesch S Brandner A Aguzzi C Weissmann Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie EMBO J 15 1996 1255 1264
20. PS Kaeser MA Klein P Schwarz A Aguzzi Efficient lymphoreticular prion propagation requires prp(c) in stromal and hematopoietic cells J Virol 75 2001 7097 7106
21. PC Klöhn L Stoltze E Flechsig M Enari C Weissmann A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions Proc Natl Acad Sci USA 100 2003 11666 11671
22. JB Schulz M Weller T Klockgether Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis. ICE-like protease activity, and reactive oxygen species J Neurosci 16 1996 4696 4706
23. J Trotter M Schachner Cells positive for the O4 surface antigen isolated by cell sorting are able to differentiate into astrocytes or oligodendrocytes Brain Res Dev Brain Res 46 1989 115 122
24. KD McCarthy J de Vellis Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue J Cell Biol 85 1980 890 902
25. J Masel N Genoud A Aguzzi Efficient inhibition of prion replication by PrP-Fc(2) suggests that the prion is a PrP(Sc) oligomer J Mol Biol 345 2005 1243 1251
26. A Aguzzi M Heikenwalder Pathogenesis of prion diseases: current status and future outlook Nat Rev Microbiol 4 2006 765 775
27. MA Klein PS Kaeser P Schwarz H Weyd I Xenarios RM Zinkernagel MC Carroll JS Verbeek M Botto MJ Walport H Molina U Kalinke H Acha-Orbea A Aguzzi Complement facilitates early prion pathogenesis Nat Med 7 2001 488 492
28. MI Combrinck VH Perry C Cunningham Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease Neuroscience 112 2002 7 11
29. A Consiglio A Quattrini S Martino JC Bensadoun D Dolcetta A Trojani G Benaglia S Marchesini V Cestari A Oliverio C Bordignon L Naldini In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice Nat Med 7 2001 310 316
30. M Moser RJ Colello U Pott B Oesch Developmental expression of the prion protein gene in glial cells Neuron 14 1995 509 517
31. M Prinz F Montrasio H Furukawa ME van der Haar P Schwarz T Rülicke O Giger KG Häusler M Glatzel A Aguzzi Intrinsic resistance of oligodendrocytes to prion infection J Neurosci 24 2004 5974 5981
32. AJ Raeber RE Race S Brandner SA Priola A Sailer RA Bessen L Mucke J Manson A Aguzzi MB Oldstone C Weissmann B Chesebro Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie EMBO J 16 1997 6057 6065
33. G Mallucci A Dickinson J Linehan PC Klohn S Brandner J Collinge Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis Science 302 2003 871 874
34. M Jeffrey CM Goodsir RE Race B Chesebro Scrapie-specific neuronal lesions are independent of neuronal PrP expression Ann Neurol 55 2004 781 792
35. A Follenzi LE Ailles S Bakovic M Geuna L Naldini Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences Nat Genet 25 2000 217 222
36. NR Cashman B Caughey Prion diseases—close to effective therapy? Nat Rev Drug Discov 3 2004 874 884
37. F Montrasio R Frigg M Glatzel MA Klein F Mackay A Aguzzi C Weissmann Impaired prion replication in spleens of mice lacking functional follicular dendritic cells Science 288 2000 1257 1259
38. NA Mabbott G McGovern M Jeffrey ME Bruce Temporary blockade of the tumor necrosis factor receptor signaling pathway impedes the spread of scrapie to the brain J Virol 76 2002 5131 5139
39. AF Hill M Zeidler J Ironside J Collinge Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy Lancet 349 1997 99 100
40. DA Hilton E Fathers P Edwards JW Ironside J Zajicek Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease Lancet 352 1998 703 704